Mesoblast Limited (MESO)
Mesoblast & BMT CTN to Initiate Adult aGvHD Trial of RYONCIL
Mesoblast & BMT CTN to Initiate Adult aGvHD Trial of RYONCIL
DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing
RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties
ClearPoint Neuro Completes Acquisition of IRRAS
DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing
UTHR: Notification
Equillium - Equillium to Participate in Upcoming Investor Conferences
Equillium to Participate in Upcoming Investor Conferences
New SEC Form for ResMed Inc.
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth